DENISE JONES: Open Payments
NPI 1013590702 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 31 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $85 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $217 |
| TerSera Therapeutics LLC | 2 | $147 |
| Collegium Pharmaceutical, Inc. | 5 | $108 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $77 |
| Medtronic, Inc. | 2 | $65 |
| Valinor Pharma, LLC | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Products named: RELISTOR, Prialt, Belbuca, JOURNAVX, MOVANTIK, GIVLAARI, SYNCHROMEDII, XTAMPZA.
Industry payments across KY — which companies pay providers there.
